
Kolon Life Science secures Brazilian patent for neuropathic pain gene therapy candidate
Korea’s Kolon Life Science said Wednesday it has secured a Brazilian patent for KLS-2031, its experimental gene therapy for neuropathic pain. The patent covers a multi-gene composition designed to silence pain signals and control inflammation. The therapy …